APO Research
Talk to an analyst

APO RESEARCH · REPORT

Total Intravenous Anesthesia (TIVA)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Total Intravenous Anesthesia (TIVA) Market Analysis and Forecast 2026-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchTotal Intravenous Anesthesia (TIVA) Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Total Intravenous Anesthesia (TIVA) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Total Intravenous Anesthesia (TIVA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Total Intravenous Anesthesia (TIVA) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Total Intravenous Anesthesia (TIVA) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Total Intravenous Anesthesia (TIVA) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Total Intravenous Anesthesia (TIVA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Total Intravenous Anesthesia (TIVA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Total Intravenous Anesthesia (TIVA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Total Intravenous Anesthesia (TIVA) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Total Intravenous Anesthesia (TIVA) include Mylan, Hengrui, B. Braun Medical, AbbVie, Astrazeneca, Piramal, Nhwa, Maruishi and Lunan, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Total Intravenous Anesthesia (TIVA), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Total Intravenous Anesthesia (TIVA), also provides the sales of main regions and countries. Of the upcoming market potential for Total Intravenous Anesthesia (TIVA), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Total Intravenous Anesthesia (TIVA) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Total Intravenous Anesthesia (TIVA) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Total Intravenous Anesthesia (TIVA) sales, projected growth trends, production technology, application and end-user industry.

Total Intravenous Anesthesia (TIVA) Segment by Company

Mylan

Hengrui

B. Braun Medical

AbbVie

Astrazeneca

Piramal

Nhwa

Maruishi

Lunan

Hikma Pharmaceuticals

Fresenius-Kabi

Baxter Healthcare

Total Intravenous Anesthesia (TIVA) Segment by Type

Barbiturates

Propofol

Midazolam

Etomidate

Others

Total Intravenous Anesthesia (TIVA) Segment by Application

Orthopedic

Cosmetic Surgeries

Predominantly Emergency

Others

Total Intravenous Anesthesia (TIVA) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Total Intravenous Anesthesia (TIVA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Total Intravenous Anesthesia (TIVA) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Total Intravenous Anesthesia (TIVA).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Total Intravenous Anesthesia (TIVA) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Total Intravenous Anesthesia (TIVA) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Total Intravenous Anesthesia (TIVA) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Total Intravenous Anesthesia (TIVA) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Barbiturates Major Manufacturers Table 3. Propofol Major Manufacturers Table 4. Midazolam Major Manufacturers Table 5. Etomidate Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Total Intravenous Anesthesia (TIVA) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Orthopedic Major Manufacturers Table 9. Cosmetic Surgeries Major Manufacturers Table 10. Predominantly Emergency Major Manufacturers Table 11. Others Major Manufacturers Table 12. Total Intravenous Anesthesia (TIVA) Industry Trends Table 13. Total Intravenous Anesthesia (TIVA) Industry Drivers Table 14. Total Intravenous Anesthesia (TIVA) Industry Opportunities and Challenges Table 15. Total Intravenous Anesthesia (TIVA) Industry Restraints Table 16. Global Total Intravenous Anesthesia (TIVA) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2021-2026) Table 20. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2027-2032) Table 21. Global Total Intravenous Anesthesia (TIVA) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Total Intravenous Anesthesia (TIVA) Sales by Region (2021-2026) & (K Units) Table 23. Global Total Intravenous Anesthesia (TIVA) Sales by Region (2027-2032) & (K Units) Table 24. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2021-2026) Table 25. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2027-2032) Table 26. Global Total Intravenous Anesthesia (TIVA) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Total Intravenous Anesthesia (TIVA) Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Manufacturers (2021-2026) Table 30. Global Total Intravenous Anesthesia (TIVA) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Total Intravenous Anesthesia (TIVA) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Total Intravenous Anesthesia (TIVA) Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Total Intravenous Anesthesia (TIVA) Manufacturers, Product Type & Application Table 34. Global Total Intravenous Anesthesia (TIVA) Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Total Intravenous Anesthesia (TIVA) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Total Intravenous Anesthesia (TIVA) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2021-2026) Table 41. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2027-2032) Table 42. Global Total Intravenous Anesthesia (TIVA) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2026) & (K Units) Table 44. Global Total Intravenous Anesthesia (TIVA) Sales by Type (2027-2032) & (K Units) Table 45. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2021-2026) Table 46. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2027-2032) Table 47. Global Total Intravenous Anesthesia (TIVA) Price by Type (2021-2026) & (US$/Unit) Table 48. Global Total Intravenous Anesthesia (TIVA) Price by Type (2027-2032) & (US$/Unit) Table 49. Global Total Intravenous Anesthesia (TIVA) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2021-2026) Table 53. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2027-2032) Table 54. Global Total Intravenous Anesthesia (TIVA) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2026) & (K Units) Table 56. Global Total Intravenous Anesthesia (TIVA) Sales by Application (2027-2032) & (K Units) Table 57. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2021-2026) Table 58. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2027-2032) Table 59. Global Total Intravenous Anesthesia (TIVA) Price by Application (2021-2026) & (US$/Unit) Table 60. Global Total Intravenous Anesthesia (TIVA) Price by Application (2027-2032) & (US$/Unit) Table 61. Mylan Company Information Table 62. Mylan Business Overview Table 63. Mylan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Mylan Total Intravenous Anesthesia (TIVA) Product Portfolio Table 65. Mylan Recent Development Table 66. Hengrui Company Information Table 67. Hengrui Business Overview Table 68. Hengrui Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Hengrui Total Intravenous Anesthesia (TIVA) Product Portfolio Table 70. Hengrui Recent Development Table 71. B. Braun Medical Company Information Table 72. B. Braun Medical Business Overview Table 73. B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Portfolio Table 75. B. Braun Medical Recent Development Table 76. AbbVie Company Information Table 77. AbbVie Business Overview Table 78. AbbVie Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. AbbVie Total Intravenous Anesthesia (TIVA) Product Portfolio Table 80. AbbVie Recent Development Table 81. Astrazeneca Company Information Table 82. Astrazeneca Business Overview Table 83. Astrazeneca Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Astrazeneca Total Intravenous Anesthesia (TIVA) Product Portfolio Table 85. Astrazeneca Recent Development Table 86. Piramal Company Information Table 87. Piramal Business Overview Table 88. Piramal Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Piramal Total Intravenous Anesthesia (TIVA) Product Portfolio Table 90. Piramal Recent Development Table 91. Nhwa Company Information Table 92. Nhwa Business Overview Table 93. Nhwa Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Nhwa Total Intravenous Anesthesia (TIVA) Product Portfolio Table 95. Nhwa Recent Development Table 96. Maruishi Company Information Table 97. Maruishi Business Overview Table 98. Maruishi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Maruishi Total Intravenous Anesthesia (TIVA) Product Portfolio Table 100. Maruishi Recent Development Table 101. Lunan Company Information Table 102. Lunan Business Overview Table 103. Lunan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Lunan Total Intravenous Anesthesia (TIVA) Product Portfolio Table 105. Lunan Recent Development Table 106. Hikma Pharmaceuticals Company Information Table 107. Hikma Pharmaceuticals Business Overview Table 108. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Portfolio Table 110. Hikma Pharmaceuticals Recent Development Table 111. Fresenius-Kabi Company Information Table 112. Fresenius-Kabi Business Overview Table 113. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Portfolio Table 115. Fresenius-Kabi Recent Development Table 116. Baxter Healthcare Company Information Table 117. Baxter Healthcare Business Overview Table 118. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Portfolio Table 120. Baxter Healthcare Recent Development Table 121. North America Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2026) & (US$ Million) Table 122. North America Total Intravenous Anesthesia (TIVA) Revenue by Type (2027-2032) & (US$ Million) Table 123. North America Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2026) & (K Units) Table 124. North America Total Intravenous Anesthesia (TIVA) Sales by Type (2027-2032) & (K Units) Table 125. North America Total Intravenous Anesthesia (TIVA) Sales Price by Type (2021-2026) & (US$/Unit) Table 126. North America Total Intravenous Anesthesia (TIVA) Sales Price by Type (2027-2032) & (US$/Unit) Table 127. North America Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2026) & (US$ Million) Table 128. North America Total Intravenous Anesthesia (TIVA) Revenue by Application (2027-2032) & (US$ Million) Table 129. North America Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2026) & (K Units) Table 130. North America Total Intravenous Anesthesia (TIVA) Sales by Application (2027-2032) & (K Units) Table 131. North America Total Intravenous Anesthesia (TIVA) Sales Price by Application (2021-2026) & (US$/Unit) Table 132. North America Total Intravenous Anesthesia (TIVA) Sales Price by Application (2027-2032) & (US$/Unit) Table 133. North America Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. North America Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. North America Total Intravenous Anesthesia (TIVA) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 137. North America Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2026) & (K Units) Table 138. North America Total Intravenous Anesthesia (TIVA) Sales by Country (2027-2032) & (K Units) Table 139. North America Total Intravenous Anesthesia (TIVA) Sales Price by Country (2021-2026) & (US$/Unit) Table 140. North America Total Intravenous Anesthesia (TIVA) Sales Price by Country (2027-2032) & (US$/Unit) Table 141. United States Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 142. Canada Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 143. Europe Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2026) & (US$ Million) Table 144. Europe Total Intravenous Anesthesia (TIVA) Revenue by Type (2027-2032) & (US$ Million) Table 145. Europe Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2026) & (K Units) Table 146. Europe Total Intravenous Anesthesia (TIVA) Sales by Type (2027-2032) & (K Units) Table 147. Europe Total Intravenous Anesthesia (TIVA) Sales Price by Type (2021-2026) & (US$/Unit) Table 148. Europe Total Intravenous Anesthesia (TIVA) Sales Price by Type (2027-2032) & (US$/Unit) Table 149. Europe Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2026) & (US$ Million) Table 150. Europe Total Intravenous Anesthesia (TIVA) Revenue by Application (2027-2032) & (US$ Million) Table 151. Europe Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2026) & (K Units) Table 152. Europe Total Intravenous Anesthesia (TIVA) Sales by Application (2027-2032) & (K Units) Table 153. Europe Total Intravenous Anesthesia (TIVA) Sales Price by Application (2021-2026) & (US$/Unit) Table 154. Europe Total Intravenous Anesthesia (TIVA) Sales Price by Application (2027-2032) & (US$/Unit) Table 155. Europe Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Europe Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Europe Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 159. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2026) & (K Units) Table 160. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2027-2032) & (K Units) Table 161. Europe Total Intravenous Anesthesia (TIVA) Sales Price by Country (2021-2026) & (US$/Unit) Table 162. Europe Total Intravenous Anesthesia (TIVA) Sales Price by Country (2027-2032) & (US$/Unit) Table 163. Germany Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 164. France Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 165. U.K. Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 166. Italy Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 167. Netherlands Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 168. China Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2026) & (US$ Million) Table 169. China Total Intravenous Anesthesia (TIVA) Revenue by Type (2027-2032) & (US$ Million) Table 170. China Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2026) & (K Units) Table 171. China Total Intravenous Anesthesia (TIVA) Sales by Type (2027-2032) & (K Units) Table 172. China Total Intravenous Anesthesia (TIVA) Sales Price by Type (2021-2026) & (US$/Unit) Table 173. China Total Intravenous Anesthesia (TIVA) Sales Price by Type (2027-2032) & (US$/Unit) Table 174. China Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2026) & (US$ Million) Table 175. China Total Intravenous Anesthesia (TIVA) Revenue by Application (2027-2032) & (US$ Million) Table 176. China Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2026) & (K Units) Table 177. China Total Intravenous Anesthesia (TIVA) Sales by Application (2027-2032) & (K Units) Table 178. China Total Intravenous Anesthesia (TIVA) Sales Price by Application (2021-2026) & (US$/Unit) Table 179. China Total Intravenous Anesthesia (TIVA) Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2026) & (US$ Million) Table 181. Asia Total Intravenous Anesthesia (TIVA) Revenue by Type (2027-2032) & (US$ Million) Table 182. Asia Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2026) & (K Units) Table 183. Asia Total Intravenous Anesthesia (TIVA) Sales by Type (2027-2032) & (K Units) Table 184. Asia Total Intravenous Anesthesia (TIVA) Sales Price by Type (2021-2026) & (US$/Unit) Table 185. Asia Total Intravenous Anesthesia (TIVA) Sales Price by Type (2027-2032) & (US$/Unit) Table 186. Asia Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2026) & (US$ Million) Table 187. Asia Total Intravenous Anesthesia (TIVA) Revenue by Application (2027-2032) & (US$ Million) Table 188. Asia Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2026) & (K Units) Table 189. Asia Total Intravenous Anesthesia (TIVA) Sales by Application (2027-2032) & (K Units) Table 190. Asia Total Intravenous Anesthesia (TIVA) Sales Price by Application (2021-2026) & (US$/Unit) Table 191. Asia Total Intravenous Anesthesia (TIVA) Sales Price by Application (2027-2032) & (US$/Unit) Table 192. Asia Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Asia Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Asia Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Asia Total Intravenous Anesthesia (TIVA) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 196. Asia Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2026) & (K Units) Table 197. Asia Total Intravenous Anesthesia (TIVA) Sales by Country (2027-2032) & (K Units) Table 198. Asia Total Intravenous Anesthesia (TIVA) Sales Price by Country (2021-2026) & (US$/Unit) Table 199. Asia Total Intravenous Anesthesia (TIVA) Sales Price by Country (2027-2032) & (US$/Unit) Table 200. Japan Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 201. South Korea Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 202. India Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 203. Australia Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 204. China Taiwan Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 205. Southeast Asia Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 206. SAMEA Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2026) & (US$ Million) Table 207. SAMEA Total Intravenous Anesthesia (TIVA) Revenue by Type (2027-2032) & (US$ Million) Table 208. SAMEA Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2026) & (K Units) Table 209. SAMEA Total Intravenous Anesthesia (TIVA) Sales by Type (2027-2032) & (K Units) Table 210. SAMEA Total Intravenous Anesthesia (TIVA) Sales Price by Type (2021-2026) & (US$/Unit) Table 211. SAMEA Total Intravenous Anesthesia (TIVA) Sales Price by Type (2027-2032) & (US$/Unit) Table 212. SAMEA Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2026) & (US$ Million) Table 213. SAMEA Total Intravenous Anesthesia (TIVA) Revenue by Application (2027-2032) & (US$ Million) Table 214. SAMEA Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2026) & (K Units) Table 215. SAMEA Total Intravenous Anesthesia (TIVA) Sales by Application (2027-2032) & (K Units) Table 216. SAMEA Total Intravenous Anesthesia (TIVA) Sales Price by Application (2021-2026) & (US$/Unit) Table 217. SAMEA Total Intravenous Anesthesia (TIVA) Sales Price by Application (2027-2032) & (US$/Unit) Table 218. SAMEA Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. SAMEA Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. SAMEA Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. SAMEA Total Intravenous Anesthesia (TIVA) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 222. SAMEA Total Intravenous Anesthesia (TIVA) Sales by Country (2021-2026) & (K Units) Table 223. SAMEA Total Intravenous Anesthesia (TIVA) Sales by Country (2027-2032) & (K Units) Table 224. SAMEA Total Intravenous Anesthesia (TIVA) Sales Price by Country (2021-2026) & (US$/Unit) Table 225. SAMEA Total Intravenous Anesthesia (TIVA) Sales Price by Country (2027-2032) & (US$/Unit) Table 226. Brazil Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 227. Argentina Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 228. Chile Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 229. Colombia Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 230. Peru Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 231. Saudi Arabia Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 232. Israel Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 233. UAE Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 234. Turkey Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 235. Iran Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 236. Egypt Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Table 237. Key Raw Materials Table 238. Raw Materials Key Suppliers Table 239. Total Intravenous Anesthesia (TIVA) Distributors List Table 240. Total Intravenous Anesthesia (TIVA) Customers List Table 241. Research Programs/Design for This Report Table 242. Authors List of This Report Table 243. Secondary Sources Table 244. Primary Sources List of Figures Figure 1. Total Intravenous Anesthesia (TIVA) Image Figure 2. Global Total Intravenous Anesthesia (TIVA) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Total Intravenous Anesthesia (TIVA) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Barbiturates Image Figure 5. Propofol Image Figure 6. Midazolam Image Figure 7. Etomidate Image Figure 8. Others Image Figure 9. Global Total Intravenous Anesthesia (TIVA) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Total Intravenous Anesthesia (TIVA) Market Size Share 2021 VS 2025 VS 2032 Figure 11. Orthopedic Image Figure 12. Cosmetic Surgeries Image Figure 13. Predominantly Emergency Image Figure 14. Others Image Figure 15. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Total Intravenous Anesthesia (TIVA) Revenue (2021-2032) & (US$ Million) Figure 17. Global Total Intravenous Anesthesia (TIVA) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2021-2032) Figure 20. Global Total Intravenous Anesthesia (TIVA) Sales (2021-2032) & (K Units) Figure 21. Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Total Intravenous Anesthesia (TIVA) Sales YoY (2021-2032) & (K Units) Figure 24. Europe Total Intravenous Anesthesia (TIVA) Sales YoY (2021-2032) & (K Units) Figure 25. China Total Intravenous Anesthesia (TIVA) Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Total Intravenous Anesthesia (TIVA) Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales YoY (2021-2032) & (K Units) Figure 28. Global Total Intravenous Anesthesia (TIVA) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Total Intravenous Anesthesia (TIVA) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2021-2032) Figure 34. Global Total Intravenous Anesthesia (TIVA) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2021-2032) Figure 37. Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2021-2032) Figure 40. Global Total Intravenous Anesthesia (TIVA) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2021-2032) Figure 43. North America Total Intravenous Anesthesia (TIVA) Revenue Share by Type (2021-2032) Figure 44. North America Total Intravenous Anesthesia (TIVA) Sales Share by Type (2021-2032) Figure 45. North America Total Intravenous Anesthesia (TIVA) Revenue Share by Application (2021-2032) Figure 46. North America Total Intravenous Anesthesia (TIVA) Sales Share by Application (2021-2032) Figure 47. North America Total Intravenous Anesthesia (TIVA) Revenue Share by Country (2021-2032) Figure 48. North America Total Intravenous Anesthesia (TIVA) Sales Share by Country (2021-2032) Figure 49. Europe Total Intravenous Anesthesia (TIVA) Revenue Share by Type (2021-2032) Figure 50. Europe Total Intravenous Anesthesia (TIVA) Sales Share by Type (2021-2032) Figure 51. Europe Total Intravenous Anesthesia (TIVA) Revenue Share by Application (2021-2032) Figure 52. Europe Total Intravenous Anesthesia (TIVA) Sales Share by Application (2021-2032) Figure 53. Europe Total Intravenous Anesthesia (TIVA) Revenue Share by Country (2021-2032) Figure 54. Europe Total Intravenous Anesthesia (TIVA) Sales Share by Country (2021-2032) Figure 55. China Total Intravenous Anesthesia (TIVA) Revenue Share by Type (2021-2032) Figure 56. China Total Intravenous Anesthesia (TIVA) Sales Share by Type (2021-2032) Figure 57. China Total Intravenous Anesthesia (TIVA) Revenue Share by Application (2021-2032) Figure 58. China Total Intravenous Anesthesia (TIVA) Sales Share by Application (2021-2032) Figure 59. Asia Total Intravenous Anesthesia (TIVA) Revenue Share by Type (2021-2032) Figure 60. Asia Total Intravenous Anesthesia (TIVA) Sales Share by Type (2021-2032) Figure 61. Asia Total Intravenous Anesthesia (TIVA) Revenue Share by Application (2021-2032) Figure 62. Asia Total Intravenous Anesthesia (TIVA) Sales Share by Application (2021-2032) Figure 63. Asia Total Intravenous Anesthesia (TIVA) Revenue Share by Country (2021-2032) Figure 64. Asia Total Intravenous Anesthesia (TIVA) Sales Share by Country (2021-2032) Figure 65. SAMEA Total Intravenous Anesthesia (TIVA) Revenue Share by Type (2021-2032) Figure 66. SAMEA Total Intravenous Anesthesia (TIVA) Sales Share by Type (2021-2032) Figure 67. SAMEA Total Intravenous Anesthesia (TIVA) Revenue Share by Application (2021-2032) Figure 68. SAMEA Total Intravenous Anesthesia (TIVA) Sales Share by Application (2021-2032) Figure 69. SAMEA Total Intravenous Anesthesia (TIVA) Revenue Share by Country (2021-2032) Figure 70. SAMEA Total Intravenous Anesthesia (TIVA) Sales Share by Country (2021-2032) Figure 71. Total Intravenous Anesthesia (TIVA) Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Total Intravenous Anesthesia (TIVA) Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Barbiturates
  • Propofol
  • Midazolam
  • Etomidate
  • Others
Applications
  • Orthopedic
  • Cosmetic Surgeries
  • Predominantly Emergency
  • Others
Companies covered
  • Mylan
  • Hengrui
  • B. Braun Medical
  • AbbVie
  • Astrazeneca
  • Piramal
  • Nhwa
  • Maruishi
  • Lunan
  • Hikma Pharmaceuticals
  • Fresenius-Kabi
  • Baxter Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Total Intravenous Anesthesia (TIVA) Market by Type
  3. 1.2.1 Global Total Intravenous Anesthesia (TIVA) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Barbiturates
  5. 1.2.3 Propofol
  6. 1.2.4 Midazolam
  7. 1.2.5 Etomidate
  8. 1.2.6 Others
  9. 1.3 Total Intravenous Anesthesia (TIVA) Market by Application
  10. 1.3.1 Global Total Intravenous Anesthesia (TIVA) Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Orthopedic
  12. 1.3.3 Cosmetic Surgeries
  13. 1.3.4 Predominantly Emergency
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Total Intravenous Anesthesia (TIVA) Market Dynamics
  1. 2.1 Total Intravenous Anesthesia (TIVA) Industry Trends
  2. 2.2 Total Intravenous Anesthesia (TIVA) Industry Drivers
  3. 2.3 Total Intravenous Anesthesia (TIVA) Industry Opportunities and Challenges
  4. 2.4 Total Intravenous Anesthesia (TIVA) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Total Intravenous Anesthesia (TIVA) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Region
  3. 3.2.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2021-2026)
  5. 3.2.3 Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2027-2032)
  6. 3.2.4 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Total Intravenous Anesthesia (TIVA) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Total Intravenous Anesthesia (TIVA) Sales by Region
  9. 3.4.1 Global Total Intravenous Anesthesia (TIVA) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Total Intravenous Anesthesia (TIVA) Sales by Region (2021-2026)
  11. 3.4.3 Global Total Intravenous Anesthesia (TIVA) Sales by Region (2027-2032)
  12. 3.4.4 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Manufacturers
  2. 4.1.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Total Intravenous Anesthesia (TIVA) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Total Intravenous Anesthesia (TIVA) Sales by Manufacturers
  6. 4.2.1 Global Total Intravenous Anesthesia (TIVA) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Total Intravenous Anesthesia (TIVA) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Total Intravenous Anesthesia (TIVA) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Total Intravenous Anesthesia (TIVA) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Total Intravenous Anesthesia (TIVA) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Total Intravenous Anesthesia (TIVA) Manufacturers, Product Type & Application
  13. 4.7 Global Total Intravenous Anesthesia (TIVA) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Total Intravenous Anesthesia (TIVA) Market CR5 and HHI
  16. 4.8.2 2025 Total Intravenous Anesthesia (TIVA) Tier 1, Tier 2, and Tier 3
5 Total Intravenous Anesthesia (TIVA) Market by Type
  1. 5.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Type
  2. 5.1.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Total Intravenous Anesthesia (TIVA) Sales by Type
  6. 5.2.1 Global Total Intravenous Anesthesia (TIVA) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Total Intravenous Anesthesia (TIVA) Price by Type
6 Total Intravenous Anesthesia (TIVA) Market by Application
  1. 6.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Application
  2. 6.1.1 Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Total Intravenous Anesthesia (TIVA) Sales by Application
  6. 6.2.1 Global Total Intravenous Anesthesia (TIVA) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Total Intravenous Anesthesia (TIVA) Price by Application
7 Company Profiles
  1. 7.1 Mylan
  2. 7.1.1 Mylan Company Information
  3. 7.1.2 Mylan Business Overview
  4. 7.1.3 Mylan Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Mylan Total Intravenous Anesthesia (TIVA) Product Portfolio
  6. 7.1.5 Mylan Recent Developments
  7. 7.2 Hengrui
  8. 7.2.1 Hengrui Company Information
  9. 7.2.2 Hengrui Business Overview
  10. 7.2.3 Hengrui Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Hengrui Total Intravenous Anesthesia (TIVA) Product Portfolio
  12. 7.2.5 Hengrui Recent Developments
  13. 7.3 B. Braun Medical
  14. 7.3.1 B. Braun Medical Company Information
  15. 7.3.2 B. Braun Medical Business Overview
  16. 7.3.3 B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Portfolio
  18. 7.3.5 B. Braun Medical Recent Developments
  19. 7.4 AbbVie
  20. 7.4.1 AbbVie Company Information
  21. 7.4.2 AbbVie Business Overview
  22. 7.4.3 AbbVie Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AbbVie Total Intravenous Anesthesia (TIVA) Product Portfolio
  24. 7.4.5 AbbVie Recent Developments
  25. 7.5 Astrazeneca
  26. 7.5.1 Astrazeneca Company Information
  27. 7.5.2 Astrazeneca Business Overview
  28. 7.5.3 Astrazeneca Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Astrazeneca Total Intravenous Anesthesia (TIVA) Product Portfolio
  30. 7.5.5 Astrazeneca Recent Developments
  31. 7.6 Piramal
  32. 7.6.1 Piramal Company Information
  33. 7.6.2 Piramal Business Overview
  34. 7.6.3 Piramal Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Piramal Total Intravenous Anesthesia (TIVA) Product Portfolio
  36. 7.6.5 Piramal Recent Developments
  37. 7.7 Nhwa
  38. 7.7.1 Nhwa Company Information
  39. 7.7.2 Nhwa Business Overview
  40. 7.7.3 Nhwa Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Nhwa Total Intravenous Anesthesia (TIVA) Product Portfolio
  42. 7.7.5 Nhwa Recent Developments
  43. 7.8 Maruishi
  44. 7.8.1 Maruishi Company Information
  45. 7.8.2 Maruishi Business Overview
  46. 7.8.3 Maruishi Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Maruishi Total Intravenous Anesthesia (TIVA) Product Portfolio
  48. 7.8.5 Maruishi Recent Developments
  49. 7.9 Lunan
  50. 7.9.1 Lunan Company Information
  51. 7.9.2 Lunan Business Overview
  52. 7.9.3 Lunan Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Lunan Total Intravenous Anesthesia (TIVA) Product Portfolio
  54. 7.9.5 Lunan Recent Developments
  55. 7.10 Hikma Pharmaceuticals
  56. 7.10.1 Hikma Pharmaceuticals Company Information
  57. 7.10.2 Hikma Pharmaceuticals Business Overview
  58. 7.10.3 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Portfolio
  60. 7.10.5 Hikma Pharmaceuticals Recent Developments
  61. 7.11 Fresenius-Kabi
  62. 7.11.1 Fresenius-Kabi Company Information
  63. 7.11.2 Fresenius-Kabi Business Overview
  64. 7.11.3 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Portfolio
  66. 7.11.5 Fresenius-Kabi Recent Developments
  67. 7.12 Baxter Healthcare
  68. 7.12.1 Baxter Healthcare Company Information
  69. 7.12.2 Baxter Healthcare Business Overview
  70. 7.12.3 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Portfolio
  72. 7.12.5 Baxter Healthcare Recent Developments
8 North America
  1. 8.1 North America Total Intravenous Anesthesia (TIVA) Market Size by Type
  2. 8.1.1 North America Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2032)
  3. 8.1.2 North America Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2032)
  4. 8.1.3 North America Total Intravenous Anesthesia (TIVA) Price by Type (2021-2032)
  5. 8.2 North America Total Intravenous Anesthesia (TIVA) Market Size by Application
  6. 8.2.1 North America Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2032)
  7. 8.2.2 North America Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2032)
  8. 8.2.3 North America Total Intravenous Anesthesia (TIVA) Price by Application (2021-2032)
  9. 8.3 North America Total Intravenous Anesthesia (TIVA) Market Size by Country
  10. 8.3.1 North America Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Total Intravenous Anesthesia (TIVA) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Total Intravenous Anesthesia (TIVA) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Total Intravenous Anesthesia (TIVA) Market Size by Type
  2. 9.1.1 Europe Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2032)
  4. 9.1.3 Europe Total Intravenous Anesthesia (TIVA) Price by Type (2021-2032)
  5. 9.2 Europe Total Intravenous Anesthesia (TIVA) Market Size by Application
  6. 9.2.1 Europe Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2032)
  8. 9.2.3 Europe Total Intravenous Anesthesia (TIVA) Price by Application (2021-2032)
  9. 9.3 Europe Total Intravenous Anesthesia (TIVA) Market Size by Country
  10. 9.3.1 Europe Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Total Intravenous Anesthesia (TIVA) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Total Intravenous Anesthesia (TIVA) Market Size by Type
  2. 10.1.1 China Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2032)
  3. 10.1.2 China Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2032)
  4. 10.1.3 China Total Intravenous Anesthesia (TIVA) Price by Type (2021-2032)
  5. 10.2 China Total Intravenous Anesthesia (TIVA) Market Size by Application
  6. 10.2.1 China Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2032)
  7. 10.2.2 China Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2032)
  8. 10.2.3 China Total Intravenous Anesthesia (TIVA) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Total Intravenous Anesthesia (TIVA) Market Size by Type
  2. 11.1.1 Asia Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2032)
  4. 11.1.3 Asia Total Intravenous Anesthesia (TIVA) Price by Type (2021-2032)
  5. 11.2 Asia Total Intravenous Anesthesia (TIVA) Market Size by Application
  6. 11.2.1 Asia Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2032)
  8. 11.2.3 Asia Total Intravenous Anesthesia (TIVA) Price by Application (2021-2032)
  9. 11.3 Asia Total Intravenous Anesthesia (TIVA) Market Size by Country
  10. 11.3.1 Asia Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Total Intravenous Anesthesia (TIVA) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Total Intravenous Anesthesia (TIVA) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Total Intravenous Anesthesia (TIVA) Market Size by Type
  2. 12.1.1 SAMEA Total Intravenous Anesthesia (TIVA) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Total Intravenous Anesthesia (TIVA) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Total Intravenous Anesthesia (TIVA) Price by Type (2021-2032)
  5. 12.2 SAMEA Total Intravenous Anesthesia (TIVA) Market Size by Application
  6. 12.2.1 SAMEA Total Intravenous Anesthesia (TIVA) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Total Intravenous Anesthesia (TIVA) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Total Intravenous Anesthesia (TIVA) Price by Application (2021-2032)
  9. 12.3 SAMEA Total Intravenous Anesthesia (TIVA) Market Size by Country
  10. 12.3.1 SAMEA Total Intravenous Anesthesia (TIVA) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Total Intravenous Anesthesia (TIVA) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Total Intravenous Anesthesia (TIVA) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Total Intravenous Anesthesia (TIVA) Value Chain Analysis
  2. 13.1.1 Total Intravenous Anesthesia (TIVA) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Total Intravenous Anesthesia (TIVA) Production Mode & Process
  6. 13.2 Total Intravenous Anesthesia (TIVA) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Total Intravenous Anesthesia (TIVA) Distributors
  9. 13.2.3 Total Intravenous Anesthesia (TIVA) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst